Andrew R Barsky, Jerry George, Andrew J Wroe, Kathryn E Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso N Gutierrez, Diane Alvarez, James McCulloch, Michael E Kasper, Minesh P Mehta, Michael D Chuong
Advances in radiotherapy (RT) technologies permit significant decreases in the dose delivered to organs at risk (OARs) for patients with esophageal cancer (EC). Novel RT modalities such as proton beam therapy (PBT) and magnetic resonance-guided radiotherapy (MRgRT), as well as motion management techniques including breath hold (BH) are expected to further improve the therapeutic ratio. However, to our knowledge, the dosimetric benefits of PBT vs MRgRT vs volumetric-modulated arc therapy (VMAT) have not been directly compared for EC...
November 23, 2023: Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists